Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition and Trading Update

8 Dec 2015 07:00

RNS Number : 2800I
Impellam Group plc
08 December 2015
 

8th December 2015

Impellam Group plc

 

Acquisition of Bartech Holding Corporation and Trading Update

Impellam Group plc ("Impellam" or "the Company") is pleased to announce that it has entered into an agreement to acquire Bartech Holding Corporation and its subsidiaries ("Bartech Group" or "Bartech") for an initial payment of $120m, which represents $88m(1) on a debt free cash free basis (the "Acquisition"). Bartech Group is one of the leading global workforce management and staffing solutions providers with many customers who are part of Fortunes Global 500. Founded in 1977, Bartech is headquartered in Southfield, Michigan, USA and currently manages more than 30,000 workers and consultants and over $3 billion of spend for clients worldwide on a run rate basis through its Managed Services programmes (MSP) and Specialist Staffing business.

The initial payment of $120m will be satisfied in cash of $115.4m, to be drawn from the Company's new 4 year £250m Revolving Credit Facility, which was recently put in place with Barclays as lead bank and includes HSBC, RBS, Wells Fargo, Fifth Third and KBC. The remainder of the initial consideration of $4.6m will be satisfied through the issue of 401,866 new ordinary shares in the Company to the vendors of Bartech (which equates to an issue price of approximately 767.5p) (the "Consideration Shares"). The shares have a lock in period of between 1 to 3 years. Deferred consideration of up to a maximum of $6m is payable in cash to the vendors of Bartech no later than April 2018, dependent on performance.

Completion of the Acquisition is conditional upon drawdown of funds required to satisfy the consideration which is expected to occur tomorrow, 9th December 2015. The Impellam Directors believe that Bartech represents a highly attractive acquisition for the Company which further accelerates the delivery of Impellam's stated strategy:

· Bartech is culturally aligned to Impellam's vision "to be the world's most trusted staffing company" and has a strong management team which will complement Impellam's existing team

· Bartech will bring increased scale to Impellam's US business and will improve conversion of gross profit ("Net Fee Income") to EBIT

· Bartech already operates under Impellam's Managed Services and Specialist Staffing segmentation, which will accelerate integration whilst expanding managed services revenues

· Bartech's Managed Services business is complementary to that of Guidant which operates in both North America and the UK, and Guidant's leadership position in the UK will support Bartech's European growth

· The enlarged customer base will provide cross selling opportunities for Impellam's North American Specialist Staffing businesses, Corestaff, SRG Woolf and s.com, as well as for Bartech's professional and technical specialist staffing business

· The acquisition is expected to be materially earnings enhancing in its first full year of ownership and thereafter(2).

For the 12 months to 31 December 2015, Bartech is expected to achieve an adjusted EBITDA of $12.8m (2014: $9.6m) on Net Fee Income of $48m (2014: $43m) and turnover of $272m (2014: $226m). As at 30 September 2015, Bartech had net assets of $21.6m. The Net Fee Income for 2014 was $26.8m in respect of Managed Services and $16.1m in respect of Specialist Staffing. 2014 EBITDA, pre central costs of $8.5m, was $8.4m for Managed Services and $9.7m for Specialist Staffing.

Bartech's CEO, David Barfield, will join the Impellam Group, becoming CEO of Impellam's North American businesses including Bartech. Mike Bixler, Impellam's current North America Managing Director for Specialist Staffing, will become Managing Director for the enlarged Specialist Staffing business, reporting to David Barfield.

Application has been made for the Consideration Shares to be admitted to trading on AIM ("Admission") with Admission expected to become effective at 8.00 am on Friday 11th December 2015.

Julia Robertson, Chief Executive Officer of Impellam Group plc, commented:

"The acquisition of Bartech is another significant step forward for Impellam and will accelerate the achievement of our strategic goals. There is a strong cultural fit between our two businesses and the combined management team in North America has an exciting opportunity to create top line growth by achieving increased market share at strong margins and bottom line growth by consistently delivering operational improvements and synergy benefits. The combination of our leadership position in the UK MSP market and the highly respected Bartech and Guidant brands in North America will enable us to offer our MSP clients a global solution delivered by experts in our local markets.

I am pleased to welcome David Barfield to the Impellam Group and I look forward to working with him, and all his new management team, as our North American businesses deliver the next stage of their growth and development."

David Barfield, CEO of Bartech, commented:

 "Bartech has a proud heritage of integrity and joining Impellam Group, a company that exemplifies the principles upon which my parents founded our firm, presents a wonderful opportunity for our loyal team members and candidates alike. Further, the collective strength of our staffing and managed services brands will deliver enhanced capabilities, breadth and scale to help us support our clients' growth objectives both in the USA and Europe. I look forward to working with Julia and leading the combined North American businesses."

 

 

Trading Update

Trading since the announcement of the interim results on 30 July 2015 has been in line with management expectations. There is currently significant disruption in the English healthcare market as a result of Government announcements regarding caps on locum pay rates and agency margins, which may have a short term financial impact on our healthcare businesses. Despite this, we remain confident that our strategy of reducing our reliance on the UK market and our market leading position in Managed Services, where we support the NHS to reduce its total cost of agency workers, will enable our healthcare businesses to outperform the market over the medium to longer term. The Company will provide a further update on second half trading early in 2016. 

Enquiries: For further information please contact the appropriate individual below:

Impellam Group plc

Julia Robertson, Chief Executive Tel: 01582 692658

Darren Mee, Group Finance Director Tel: 01582 692658

 

Cenkos Securities plc (Nominated Adviser and Broker to Impellam)

Nicholas Wells / Mark Connelly Tel: 020 7397 8900

 

Note to Editors:

Impellam Group plc, traded on the AIM (Symbol: IPEL) is a leading provider of managed services and specialist staffing expertise and is primarily based in the UK and North America, with smaller operations in Asia Pacific, Ireland and mainland Europe. Impellam Group plc provides fulfilling jobs at all levels, including doctors, lawyers, accountants, nurses, teachers, scientists, receptionists, drivers, chefs, administrators, engineers, technology specialists, cleaners, security guards, and manufacturing and warehouse operatives. Impellam Group plc is the 2nd largest staffing business in the UK and 12th largest worldwide, employing over 2,800 people across 234 worldwide locations.

Supplementary Notes

(1) The debt free cash free price of $88m is based on the average cash balance of Bartech during its financial year FY15. The actual cash balance will depend on the date of closing, expected to be the day following this announcement.

(2)  This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Impellam will necessarily match or exceed the historic reported earnings per share of Impellam.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUGGGGPUPAPUM
Date   Source Headline
22nd Mar 20247:00 amRNSCancellation - IMPELLAM GROUP PLC
21st Mar 202410:36 amRNSScheme of Arrangement becomes Effective
21st Mar 20247:30 amRNSSuspension - Impellam Group plc
19th Mar 20243:59 pmRNSCourt Sanction of the Scheme of Arrangement
18th Mar 20246:00 pmRNSImpellam Group
15th Mar 202411:46 amRNSForm 8.3 - Impellam Group PLC
15th Mar 202410:58 amRNSForm 8.5 (EPT/RI)
15th Mar 20248:36 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Mar 20247:00 amRNSBidco Share Capital Adjustments
14th Mar 20243:30 pmRNSForm 8.3 - IPEL LN
14th Mar 202412:10 pmRNSForm 8.3 - Impellam Group PLC
14th Mar 20248:30 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
12th Mar 20247:00 amRNSUpdate on Declaration of Dividend in Specie
11th Mar 20241:48 pmRNSForm 8.3 - Impellam Groupl plc
4th Mar 20247:00 amRNSUpdate on Offer Conditions and Timetable
27th Feb 20248:17 amRNSForm 8.5 (EPT/RI)
27th Feb 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
26th Feb 20243:27 pmRNSForm 8.3 - Impellam Group Plc
23rd Feb 20242:44 pmRNSForm 8.5 (EPT/RI)
23rd Feb 20247:22 amRNSTransaction in Own Shares & Rule 2.9 Announcement
22nd Feb 20249:10 amRNSForm 8.5 (EPT/RI)
21st Feb 20243:46 pmRNSUpdate on Offer Conditions
21st Feb 202410:09 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
15th Feb 202410:12 amRNSForm 8.3 - Impellam Group Plc
14th Feb 20241:06 pmRNSForm 8.3 - Impellam Group Plc
14th Feb 20247:41 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
13th Feb 202411:21 amRNSForm 8.3 - Impellam Group PLC
8th Feb 20247:00 amRNSDeclaration of Dividend in Specie
7th Feb 20242:21 pmRNSForm 8.3 - Impellam Group PLC
1st Feb 202412:12 pmRNSForm 8.3 - Impellam Group PLC
1st Feb 202411:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
25th Jan 202410:29 amRNSForm 8.5 (EPT/RI)
25th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
24th Jan 20247:00 amRNSSpecial Cash Dividend Declaration
23rd Jan 202411:56 amRNSForm 8.5 (EPT/RI)
23rd Jan 20248:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
23rd Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
22nd Jan 20249:27 amRNSForm 8.5 (EPT/RI)
22nd Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
19th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
19th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
18th Jan 202411:08 amRNSForm 8.5 (EPT/RI)
18th Jan 20249:20 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
18th Jan 20247:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
17th Jan 20245:01 pmRNSResults of Court Meeting and General Meeting
16th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
12th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
11th Jan 20243:30 pmRNSForm 8.3 - IPEL LN
11th Jan 20242:05 pmRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.